212 related articles for article (PubMed ID: 31804702)
1. Ceramides and sphingosine-1-phosphate as potential markers in diagnosis of ischaemic stroke.
Fiedorowicz A; Kozak-Sykała A; Bobak Ł; Kałas W; Strządała L
Neurol Neurochir Pol; 2019; 53(6):484-491. PubMed ID: 31804702
[TBL] [Abstract][Full Text] [Related]
2. Decreased Serum Levels of Sphingomyelins and Ceramides in Sickle Cell Disease Patients.
Aslan M; Kıraç E; Kaya S; Özcan F; Salim O; Küpesiz OA
Lipids; 2018 Mar; 53(3):313-322. PubMed ID: 29663386
[TBL] [Abstract][Full Text] [Related]
3. Diverse Sphingolipid Profiles in Rectal and Colon Cancer.
Markowski AR; Błachnio-Zabielska AU; Pogodzińska K; Markowska AJ; Zabielski P
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446046
[TBL] [Abstract][Full Text] [Related]
4. Serum Sphingolipidomic Analysis in Acne Vulgaris Patients.
Kaya S; Aslan İ; Kıraç E; Karaarslan T; Aslan M
Ann Clin Lab Sci; 2019 Mar; 49(2):242-248. PubMed ID: 31028071
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine 1-phosphate breakdown in platelets.
Yatomi Y; Yamamura S; Hisano N; Nakahara K; Igarashi Y; Ozaki Y
J Biochem; 2004 Oct; 136(4):495-502. PubMed ID: 15625319
[TBL] [Abstract][Full Text] [Related]
6. Differences in plasma levels of long chain and very long chain ceramides between African Americans and whites: An observational study.
Buie JNJ; Hammad SM; Nietert PJ; Magwood G; Adams RJ; Bonilha L; Sims-Robinson C
PLoS One; 2019; 14(5):e0216213. PubMed ID: 31067249
[TBL] [Abstract][Full Text] [Related]
7. Structural requirements of ceramide and sphingosine based inhibitors of mitochondrial ceramidase.
Usta J; El Bawab S; Roddy P; Szulc ZM; Yusuf ; Hannun A; Bielawska A
Biochemistry; 2001 Aug; 40(32):9657-68. PubMed ID: 11583166
[TBL] [Abstract][Full Text] [Related]
8. Regulation by sphingolipids of the fate of FRTL-5 cells.
Satoh Y; Li X; Yokota H; Osada M; Ozaki Y; Katoh R; Yatomi Y
J Biochem; 2009 Jan; 145(1):31-6. PubMed ID: 18953023
[TBL] [Abstract][Full Text] [Related]
9. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.
Kihara A; Mitsutake S; Mizutani Y; Igarashi Y
Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104
[TBL] [Abstract][Full Text] [Related]
10. Investigating sphingolipids as biomarkers for the outcomes of acute ischemic stroke patients receiving endovascular treatment.
Lee TH; Cheng CN; Lee CW; Kuo CH; Tang SC; Jeng JS
J Formos Med Assoc; 2023 Jan; 122(1):19-28. PubMed ID: 36184387
[TBL] [Abstract][Full Text] [Related]
11. Blood ceramides as novel markers for renal impairment in systemic lupus erythematosus.
Patyna S; Büttner S; Eckes T; Obermüller N; Bartel C; Braner A; Trautmann S; Thomas D; Geiger H; Pfeilschifter J; Koch A
Prostaglandins Other Lipid Mediat; 2019 Oct; 144():106348. PubMed ID: 31301404
[TBL] [Abstract][Full Text] [Related]
12. Sphingolipidomic profile and HDL subfractions in obese dyslipidemic type 2 diabetic patients.
Aslan İ; Aydın D; Koca Y; Yılmaz Ç; Çeker T; Öztüzün A; Aslan M
Prostaglandins Other Lipid Mediat; 2023 Jun; 166():106719. PubMed ID: 36863606
[TBL] [Abstract][Full Text] [Related]
13. Serum sphingolipidomic analyses reveal an upregulation of C16-ceramide and sphingosine-1-phosphate in hepatocellular carcinoma.
Grammatikos G; Schoell N; Ferreirós N; Bon D; Herrmann E; Farnik H; Köberle V; Piiper A; Zeuzem S; Kronenberger B; Waidmann O; Pfeilschifter J
Oncotarget; 2016 Apr; 7(14):18095-105. PubMed ID: 26933996
[TBL] [Abstract][Full Text] [Related]
14. Increase in circulating sphingosine-1-phosphate and decrease in ceramide levels in psoriatic patients.
Myśliwiec H; Baran A; Harasim-Symbor E; Choromańska B; Myśliwiec P; Milewska AJ; Chabowski A; Flisiak I
Arch Dermatol Res; 2017 Mar; 309(2):79-86. PubMed ID: 27988894
[TBL] [Abstract][Full Text] [Related]
15. Persistence of HCV in Acutely-Infected Patients Depletes C24-Ceramide and Upregulates Sphingosine and Sphinganine Serum Levels.
Grammatikos G; Dietz J; Ferreiros N; Koch A; Dultz G; Bon D; Karakasiliotis I; Lutz T; Knecht G; Gute P; Herrmann E; Zeuzem S; Mavromara P; Sarrazin C; Pfeilschifter J
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27304952
[TBL] [Abstract][Full Text] [Related]
16. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis.
Maceyka M; Payne SG; Milstien S; Spiegel S
Biochim Biophys Acta; 2002 Dec; 1585(2-3):193-201. PubMed ID: 12531554
[TBL] [Abstract][Full Text] [Related]
17. Targeting sphingosine kinase 1 (SK1) enhances oncogene-induced senescence through ceramide synthase 2 (CerS2)-mediated generation of very-long-chain ceramides.
Trayssac M; Clarke CJ; Stith JL; Snider JM; Newen N; Gault CR; Hannun YA; Obeid LM
Cell Death Dis; 2021 Jan; 12(1):27. PubMed ID: 33414460
[TBL] [Abstract][Full Text] [Related]
18. Biophysical properties of sphingosine, ceramides and other simple sphingolipids.
Goñi FM; Sot J; Alonso A
Biochem Soc Trans; 2014 Oct; 42(5):1401-8. PubMed ID: 25233422
[TBL] [Abstract][Full Text] [Related]
19. The potential serum sphingolipid biomarkers for distinguishing Wilson disease.
Tang S; Liang C; Yu H; Hou W; Hu Z; Chen X; Duan Z; Zheng S
Clin Chim Acta; 2024 Jan; 553():117740. PubMed ID: 38145643
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels of ceramides relate to ischemic stroke risk and clinical severity.
Gui YK; Li Q; Liu L; Zeng P; Ren RF; Guo ZF; Wang GH; Song JG; Zhang P
Brain Res Bull; 2020 May; 158():122-127. PubMed ID: 32165273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
